# Mineralys Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:03584097-785e-40d5-8b99-2cabf560d6e0 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/mineralys-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 17 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-12T21:31:19.628491+00:00 |
| Last reviewed | 2026-09-12T21:31:19.628491+00:00 |

## Identity

- Legal name: Mineralys Therapeutics, Inc.
- Display name: Mineralys Therapeutics, Inc.

## Leadership

- Glenn P. Sblendorio: Chairman. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Alexander Gold, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Brian Taylor Slingsby, M.D., Ph.D., M.P.H.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Daphne Karydas: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Derek DiRocco, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Jon Congleton: President and Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Srinivas Akkaraju, M.D., Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Adam Levy: Chief Financial Officer and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Anton J. Levy: Chief Financial Officer and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:3.
- David Rodman: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:3.
- David Rodman, M.D.: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.
- Eric Warren: Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:3.
- Eric Warren, R.Ph.: Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:4.
- Jon Congleton: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Mineralys Therapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:1.

## Headquarters

- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

## Entity Status

- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:1.

## Published Fact

- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:1.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/mineralys-therapeutics-inc).
- alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:2: [SEC DEF 14A 0001933414-26-000069](https://www.sec.gov/Archives/edgar/data/1933414/000193341426000069/mlys-20260408.htm).
- alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:3: [MLYS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1933414/000193341426000056/mlys-20251231.htm).
- alpha:evidence:company:03584097-785e-40d5-8b99-2cabf560d6e0:4: MLYS executive roster source.

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
- Current index memberships: Unavailable
- Index membership events: Unavailable

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/mineralys-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/mineralys-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/mineralys-therapeutics-inc` at https://mcp.alpha.ac/mcp
